Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
LISINOPRIL CLEARS FDA AFTER 20-MONTH REVIEW; MERCK SECOND-GENERATION ACE PRODUCT WILL BE COMARKETED BY STUART; FIRMS HEAVILY PROMOTING BRANDS TO MDs
Jan 04 1988
•
By
The Pink Sheet
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Archive
More from Pink Sheet